Centers for Disease Control and Prevention | Information about COVID-19 vaccines for people with allergies |
---|---|
Centers for Disease Control and Prevention | Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States |
Centers for Disease Control and Prevention.
3Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations | mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants |
---|---|
Centers for Disease Control and Prevention | Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U |
.
Centers for Disease Control and Prevention | V-safe after vaccination health checker |
---|---|
What to expect after getting a COVID-19 vaccine | Vaccine Adverse Event Reporting System |